Tightening Privacy Laws And Fierce Competition Will Undermine Genetic Testing
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 12 Analysts
Published
07 Aug 25
Updated
16 Aug 25
AnalystLowTarget's Fair Value
US$3.50
72.0% overvalued intrinsic discount16 Aug
US$6.02
1Y
-78.2%7D
5.4%